Accès ouvert

Systemic Metabolic Regulators as Therapeutic Targets in Alzheimer’s Disease-Related Neuroinflammation: A Scoping Review Protocol v1

Article scientifique 2026 Autre

Résumé

This scoping review maps the current evidence on systemic metabolic regulators (insulin resistance, GLP-1 signalling, adipokines, AMPK, PPARγ, ketogenic metabolism, and organokines) as therapeutic targets in inflammaging-driven neuroinflammation and Alzheimer’s disease. Particular emphasis is placed on their potential for precision medicine applications. The review follows JBI methodology and PRISMA-ScR reporting standards.

Citer ce document

Oladipo, E., Ogunniran, J., Akinpelu, S., ADEGBOLA, B. (2026). Systemic Metabolic Regulators as Therapeutic Targets in Alzheimer’s Disease-Related Neuroinflammation: A Scoping Review Protocol v1. https://doi.org/10.17504/protocols.io.e6nvwxjkzgmk/v1

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Elijah Kolawole Oladipo James Akinwumi Ogunniran Samuel Oluwaseyi Akinpelu BLESSING ADEGBOLA

Statistiques

Consultations : 1

Téléchargements : 0